• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Market Analysis Latest ASX News

Medibank [ASX:MPL] Q4 Expectations and Cyberattack Update

Like 0

By Mahlia Stewart, Tuesday, 02 May 2023

Private health insurance group Medibank presented at the Macquarie conference this morning, addressing expectations for Q4 and 2023 performance and shedding some light on the 2022 cyberattack.

Recently, one of the largest Australian private health insurance providers, Medibank Private [ASX:MPL] was the subject of a vicious cyberattack that targeted the personal data and health information of around 10 million members.

Today, the group finally shed some light on the cost involved in recovering and protecting the lost customer information at the group’s investor presentation at the Macquarie conference this morning.

MPL kept mostly flat in the share market shortly after, around $3.53 a share.

The stock holds strong in its sector at a 15% advantage, and it has increased by nearly 20% so far in 2023, up 11% on the market average:

ASX:MPL Medibank Private stock chart news 2023

Source: Market Index

Medibank’s cyberattack update

Late last year, Medibank was at the centre of a mega cyberattack scandal that rocked the media, the public and the markets.

The company, which consists of more than 3.7 million customers, claimed the hacker had stolen 200GB of data and brandished 100 policies as evidence it was not bluffing.

Among the information stolen by the hackers were names of customers, addresses, birth dates, Medicare numbers, claims information, and possible credit card numbers.

The insurance provider has been under some fire for not being more transparent during the investigations that soon ensued, accused of preferring to keep the public in the dark about details of the attack as ongoing findings progressed, but today it had something to say.

The group declared about $45 million is expected to be incurred due to the recovery and protection of lost customer information, as told at today’s Macquarie conference.

The cybercrime costs are expected to be at the top end of the $40–45 million range, not counting class action suits or other legal and regulatory-related costs that will undoubtedly be linked to the event.

Deloitte, the investigating body, has made recommendations to enhance Medibank’s IT processes and systems, several of which Medibank says have already been implemented.

The group concluded: ‘At this stage we do not expect a material increase to recurring IT costs resulting from the cybercrime.’

 

Medibank’s Q4 and 2023 expectations

The company also looked to its performance in the near future and said that there could be double non-resident gross profit in FY23.

It stated that policyholder growth increased by 0.02% at the end of March, which was reported in comparison with the prior year.

Medibank expressed expectations for a strong fourth quarter, claiming positive momentum will lead into fiscal 2024, and expects to announce another ‘customer give back’ before 30 June this year.

With students and visa workers returning to Australia after the pandemic drought, the group managed to up its fiscal year-to-date policy unit growth from 62,000 to 258,500 by the end of the March quarter.

Medibank expects FY23 industry policyholder growth to grow by 2%, compared with 2.7% growth in FY22.

The group says it is well-positioned to address the cost-of-living concerns and health needs through continued investment in dual brand propositions.

The company said:

‘Our strategy continues to meet the changing needs of customers while generating value for shareholders and bringing about much needed change in the health system.

‘We continue to expand our reach in health in both the private and public system, building strong relationships with multiple health providers with new relationships.’

ASX:MPL Medibank Private policyholder growthASX:MPL Medibank Private policy holder volumes

 

Source: MPL

 

The state of the Australian economy

The economic trade system is breaking.

The change is all around us, from the wavering global supply chain to the bare supermarket shelves.

Bank branches are closing, prices are soaring, food packets are shrinking, and workforces are struggling.

Top financial and geopolitical analyst Jim Rickards has been joining the dots and mapping it all out.

He’s realised it’s all a part of something bigger.

The changes we see now are nothing in comparison to what will be.

If you want to know how you can prepare for the biggest geoeconomic shift of our lifetime, and get an explanation from Jim Rickards himself, click here to learn more.

 

Regards,

Mahlia Stewart,

For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Mahlia Stewart

Mahlia’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • From geek to God: the trillion dollar maven
    By Callum Newman

    Here’s a few things I discovered this month after reading The Thinking Machine: Jensen Huang, Nvidia, and the World’s Most Coveted Microchip. If you want to be a billionaire, have a read of this!

  • The stock market prices in peace in the Middle East
    By Brian Chu

    Will the conflict between Israel and Iran escalate? Today, I present my views on why it could de-escalate sooner than many are made to believe.

  • Ignore the bores and the bears: some shares are going gangbusters
    By Callum Newman

    All year you and I have been on a mission. It’s to discover if now is the time to be upping your exposure to risk assets, or dialling it down. I put my stake in the ground ages ago: get bullish! It’s working.

Primary Sidebar

Latest Articles

  • From geek to God: the trillion dollar maven
  • The stock market prices in peace in the Middle East
  • Ignore the bores and the bears: some shares are going gangbusters
  • The Perfect Marriage: Combining Fundamental AND Technical Analysis
  • Your best chance to be in the top 10% will come from here

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988